Inhibition of phospholipase A₂ from Naja haje and Naja nigricollis venoms by active fraction of Moringa oleifera leaves: in vitro and in silico methods

References

• Abubakar, M.S., et al., 2000. The in vitro snake venom detoxifying action of the leaf extract of Guiera senegalensis. Journal of ethnopharmacology, 69 (3), 253–257.
   PubMed Web of Science ®Google Scholar
• Adeyi, A.O., et al., 2020. Antivenom activity of Moringa oleifera leaves against pathophysiological alterations, somatic mutation and biological activities of Naja nigricollis venom. Scientific African, 8, e00356.
   Google Scholar
• Adeyi, O.A., et al., 2021. Moringa oleifera leaf fractions attenuated Naja haje venom-induced cellular dysfunctions via modulation of Nrf2 and inflammatory signalling pathways in rats. Biochemistry and biophysics reports, 25, 100890.
   PubMedGoogle Scholar
• Akinloye, O.A., et al., 2020. Phytosterols demonstrate selective inhibition of COX-2: In-vivo and in-silico studies of Nicotiana tabacum. Bioorganic chemistry, 102, 104037.
   PubMed Web of Science ®Google Scholar
• Calvete, J.J., 2011. Proteomics in venom research: a focus on PLA2 molecules. Acta chim sloven, 58 (4), 629–637.
   PubMed Web of Science ®Google Scholar
• Caratsch, C.G., et al., 1985. Influence of divalent cations on phospholipase-dependent action of bungarotoxin at frog neuromuscular. The journal of physiology, 319, 179–191.
   Google Scholar
• Cavalcante, W.L.G., et al., 2007. Neutralization of snake venom phospholipase A2 toxins by aqueous extract of Casearia sylvestris (Flacourtiaceae) in mouse neuromuscular preparation. Journal of ethnopharmacology, 112 (3), 490–497.
   PubMed Web of Science ®Google Scholar
• Chang, J., Musser, J., and McGregor, H., 1987. Phospholipase A2: function and pharmacological regulation. Biochemical pharmacology., 36, 24–29.
   Web of Science ®Google Scholar
• Cheng, F., et al., 2012. admetSAR: a comprehensive source and free tool for evaluating chemical ADMET properties. Journal of chemical information and modeling, 52 (11), 3099–3105.
   PubMed Web of Science ®Google Scholar
• da Silva, S.L., et al., 2008. Molecular modeling of the inhibition of enzyme PLA2 from snake venom by dipyrone and 1-phenyl-3-methyl-5-pyrazolone. International journal of quantum chemistry, 108 (13), 2576–2585.
   Web of Science ®Google Scholar
• Davis, T.P., Sanchez-Covarubias, L., and Tome, M.E., 2014. P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery. Advances in pharmacology, 71, 25–44.
   PubMedGoogle Scholar
• Dennis, E.A., et al., 2011. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chemical reviews, 111 (10), 6130–6185.
   PubMed Web of Science ®Google Scholar
• Diogo, L.C., et al., 2009. Inhibition of snake venoms and phospholipases A2 by extracts from native and genetically modified Eclipta alba: isolation of active coumestans. Basic & clinical pharmacology & Toxicology, 104 (4), 293–299.
   PubMed Web of Science ®Google Scholar
• Francis, B., et al., 1995. Aminoacid sequence of a new type of toxic phospholipase A2 from the venom of Australian tiger snake (Notechis scutatus scutatus). Archives of biochemistry and biophysics, 318 (2), 481–488.
   PubMed Web of Science ®Google Scholar
• Goa, J., 1953. A micro biuret method for protein determination. Determination of total protein in cerebrospinal fluid. Scandinavian journal of clinical and laboratory investigation, 5 (3), 218–222.
   PubMed Web of Science ®Google Scholar
• Gutierrez, J.M., and Lomonte, B., 2013. Phospholipases A2: unveiling the secrets of a functionally versatile group of snake venom toxins. Toxicon 62, 27–39.
   PubMed Web of Science ®Google Scholar
• Gutierrez, J.M., et al., 2010. Snake bite envenoming from a global perspective: Towards an integrated approach. Toxicon 56 (7), 1223–1235.
   PubMed Web of Science ®Google Scholar
• Habib, A.G., 2013. Public health aspects of snakebite care in West Africa: perspectives from Nigeria. The journal of venomous animals and toxins including tropical diseases, 19 (1), 27–35.
   PubMedGoogle Scholar
• Hasson, S.S., et al., 2010. Antisnake venom activity of Hibiscus aethiopicus L. against Echisocellatus and Najanigricollis. Journal of toxicology, 2010, 1–8.
   Google Scholar
• Kini, R.M., 2003. Excitement ahead: Structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 42 (8), 827–840.
   PubMed Web of Science ®Google Scholar
• Kunjam, S.R., Jadhav, S.K., and Tiwari, K.L., 2012. Traditional herbal medicine for the treatment of snake bite and scorpion sting by the tribe of South Surguja, Chhattisgarh, India. Med aromat plants, 2, 2.
   Google Scholar
• Laemmli, U.K., 1970. Cleavage of structural proteins during the assembly of heads of bacteriophage T4. Nature, 227 (5259), 680–685.
   PubMed Web of Science ®Google Scholar
• Laila, M.G., et al., 2019. Biochemical and kinetic properties of crude phospholipase a2 from Naja nigricollis venom. Science world journal, 62, 64.
   Google Scholar
• Lipinski, C.A., 2001. Avoiding investment in doomed drugs. Curr drug discov, 1, 17–19.
   Google Scholar
• Luiselli, L., Angelici, F.M., and Akani, G.C., 2002. Comparative feeding strategies and dietary plasticity of the sympatric cobras Naja melanoleuca and Naja nigricollis in three diverging Afrotropical habitats. Canadian journal of zoology, 80 (1), 55–63.
   Google Scholar
• Mackessy, S. P., 2010. The field of reptile toxinology snakes, lizards, and their venoms, In: Handbook of venoms and toxins of reptiles, S. P. Mackessy, 1st Ed. p. 3–19. Boca Raton, Florida.
   Google Scholar
• Mebs, D., 1970. A comparitive study of enzyme activities in snake venoms. International journal of biochemistry, 1 (3), 335–342.
   Google Scholar
• Mors, W.B., et al., 2000. Plant natural products active against snake bite—the molecular approach. Phytochemistry, 55 (6), 627–642.
   PubMed Web of Science ®Google Scholar
• Neves-Ferreira, A. G. C., et al., 2010. Natural inhibitors: innate immunity to snake venoms. In Handbook of venoms and toxins of reptiles. Mackessy S.P (Ed.). Boca Raton, Florida: CRC Press, pp. 259–284.
   Google Scholar
• O’Shea, M., 2005. Venomous snakes of the world. London: New Holland.
   Google Scholar
• Osamudiamen, P.M., et al., 2017. Isolation, characterization, and in-vitro anti-cancer activity of bioactive Cassane Diterpenoids from the roots of Mezoneuron benthamianum (Baill.). Journal of biologically active products from nature, 7 (3), 157–165.
   Google Scholar
• Perumal, V., et al., 2014. Spotted nanoflowers’: Gold-seeded zinc oxide nanohybrid for Selective capture. Scientific reports, 5, 12231.
   Web of Science ®Google Scholar
• Sallau, A.B., et al., 2008. Characterization of phospholipase A2 (PLA2) from Echis ocellatus venom. African journal of biochemistry research, 2, 98–101.
   Google Scholar
• Schneider, G., 2013. Prediction of drug-like properties. Madame curie bioscience database [Internet]. Landes Bioscience.; 2000-2013. Available from: https://www.ncbi.nlm.nih.gov/books/NBK6404/
   Google Scholar
• Scott, D.L., and Sigler, P.B., 1994. Structure and catalytic mechanism of secretory PLA2. Advances in protein chemistry, 43, 53–58.
   Google Scholar
• Shashidharamurthy, R., and Kemparaju, K., 2006. A neurotoxic phospholipase A2 variant: Isolation and characterization from eastern regional Indian cobra (Naja naja). Toxicon, 47 (7), 727–733.
   PubMed Web of Science ®Google Scholar
• Shityakov, S., and Förster, C., 2014. In-silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions. Advances and applications in bioinformatics and chemistry, 7, 1–9.
   Google Scholar
• Shuting, L.I., et al., 2004. Proteomic characterization of two snake venoms: Naja najaatra and Agkistrodonhalys. The biochemical journal, 384 (Pt 1), 119–127.
   PubMedGoogle Scholar
• Singh, G., et al., 2005. Crystal structure of the complex formed between a group I phospholipase A2 and a naturally occurring fatty acid at 2.7 A resolution. Protein science: a publication of the protein society, 14 (2), 395–400.
   PubMed Web of Science ®Google Scholar
• St-Germain, M.E., et al., 2004. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Molecular cancer, 3, 7.
   PubMed Web of Science ®Google Scholar
• Theakston, R.D.G., Warrell, D.A., and Griffiths, E., 2003. Report of a WHO workshop on the standardization and control of antivenoms. Toxicon, 41 (5), 541–557.
   PubMed Web of Science ®Google Scholar
• Tohamy, A.A., et al., 2014. Biological effects of Naja haje crude venom on the hepatic and renal tissues of mice. Journal of king saud university, science, 26 (3), 205–212.
   Google Scholar
• Wagenen, B.C., et al., 1993. Ulosantoin, a potent insecticide from the sponge Ulosaruetzleri. The journal of organic chemistry, 58 (2), 335–337.
   Web of Science ®Google Scholar
• Warrell, D.A., 2011. Snake bite. Seminar. Lancet, 375, 1. Archived from the original (PDF) on 29 October 2013.
   Web of Science ®Google Scholar
• World Health 1998. Organization, WHO monographs on the selected medicinal plants. WHO Geneva.
   Google Scholar
• Yamashita, T., Brahmadathan, U.M., and Paramaswaran, M.K., 2010. Traditional poison-healing system in Kerala: An overview. Ejournal indian med, 3, 101–703.
   Google Scholar
• Yang, C.C., 1994. Structure-function relationship of PLA2 from snake venoms. Journal of toxicology, 13 (2), 125–177.
   Web of Science ®Google Scholar
• Ziganshin, R.H., et al., 2015. Quantitative proteomic analysis of Vietnamese krait venoms: neurotoxins are the major components in Bungarus multicinctus and phospholipases A2 in Bungarus fasciatus. Toxicon, 107 (Pt B), 197–209.
   PubMedGoogle Scholar